Northern Financial Advisors’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$310K Buy
+11,031
New +$294K 0.23% 93
2025
Q4
Sell
-11,119
Closed -$283K 111
2025
Q3
$283K Buy
11,119
+2,262
+26% +$55.8K 0.15% 106
2025
Q2
$215K Sell
8,857
-563
-6% -$13.1K 0.16% 103
2025
Q1
$239K Sell
9,420
-3,890
-29% -$102K 0.2% 98
2024
Q4
$353K Buy
+13,310
New +$361K 0.28% 85
2023
Q4
Sell
-8,208
Closed -$272K 121
2023
Q3
$272K Sell
8,208
-11,741
-59% -$415K 0.25% 98
2023
Q2
$732K Sell
19,949
-2,200
-10% -$85.6K 0.64% 49
2023
Q1
$904K Buy
22,149
+2,375
+12% +$103K 0.85% 39
2022
Q4
$1.01M Buy
+19,774
New +$948K 1.15% 30

Other funds holding PFE

Northern Financial Advisors's PFE Position: Q1 2026 in Review

Northern Financial Advisors opened a new position in Pfizer (PFE) in Q1 2026: 11,031 shares worth $310K. The stake represents 0.23% of the portfolio and ranks #93 among its holdings. This is a return to the name: Northern Financial Advisors previously reported a position in PFE as recently as Q3 2025.

Northern Financial Advisors first reported a position in PFE in Q4 2022 and has held it in 9 quarters since. The position peaked at $1.01M in Q4 2022. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Northern Financial Advisors held 11,031 shares of Pfizer worth $310K as of Q1 2026.
  • Pfizer was a new Northern Financial Advisors position in Q1 2026.
  • Pfizer made up 0.23% of Northern Financial Advisors's portfolio in Q1 2026, its #93 holding.
  • Northern Financial Advisors first reported a position in Pfizer in Q4 2022 and has held it in 9 quarters since.
  • Northern Financial Advisors's Pfizer position peaked at $1.01M in Q4 2022.
  • 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Northern Financial Advisors's 13F filing for Q1 2026, filed 28 Apr 2026.